Xiong, Chongxiang <br/><br/>
Pharmacological inhibition of Src kinase protects against acute kidney injury in a murine model of renal ischemia/reperfusion.  [electronic resource] 

 -  Oncotarget  May 2017 
 - 31238-31253 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.16114  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Kidney Injury--drug therapy<br/>Adherens Junctions--metabolism<br/>Animals<br/>Apoptosis--drug effects<br/>Disease Models, Animal<br/>Enzyme Activation--drug effects<br/>Epithelial Cells--drug effects<br/>Kidney Function Tests<br/>Kidney Tubules--drug effects<br/>Macrophages--metabolism<br/>Mice<br/>Mitogen-Activated Protein Kinase 1--metabolism<br/>Mitogen-Activated Protein Kinase 3--metabolism<br/>NF-kappa B--metabolism<br/>Protective Agents--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Pyrazoles--pharmacology<br/>Pyrimidines--pharmacology<br/>Reperfusion Injury--drug therapy<br/>STAT3 Transcription Factor--metabolism<br/>Tight Junction Proteins--metabolism<br/>src-Family Kinases--antagonists & inhibitors